Mary Cohen-Williams Selected Research

Alzheimer Disease (Alzheimer's Disease)

1/2013	The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer's disease.
11/2012	Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary Cohen-Williams Research Topics

Disease

2	Alzheimer Disease (Alzheimer's Disease) 01/2013 - 11/2012
2	Parkinson Disease (Parkinson's Disease) 04/2011 - 02/2009
1	Catalepsy 02/2009
1	Hyperalgesia 01/2008
1	Neuralgia (Stump Neuralgia) 01/2008
1	Psychotic Disorders (Schizoaffective Disorder) 01/2008
1	Schizophrenia (Dementia Praecox) 01/2008

Drug/Important Bio-Agent (IBA)

2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 04/2011 - 02/2009
1	Gamma Secretase Inhibitors and ModulatorsIBA 01/2013
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2012
1	2- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA 02/2009
1	PyrimidinesIBA 02/2009
1	Haloperidol (Haldol)FDA LinkGeneric 02/2009
1	pyrimidineIBA 02/2009
1	Voltage-Gated Sodium ChannelsIBA 01/2008
1	Analgesics (Analgesic Drugs)IBA 01/2008
1	Fluphenazine (Prolixin)FDA LinkGeneric 01/2008
1	Antipsychotic Agents (Antipsychotics)IBA 01/2008

Therapy/Procedure

1	Ligation 01/2008